---------------------------------------------------------------------------
              UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                           Washington, D.C. 20549

                                 FORM 10-QSB
                      QUARTERLY OR TRANSITIONAL REPORT

[X]   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES 
      EXCHANGE ACT OF 1934

              For the Quarterly Period Ended September 30, 2005

[ ]   TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT

                  Commission File Number          000-25039

                      BRAVO! FOODS INTERNATIONAL CORP.
       (Exact name of registrant as specified in its amended charter)

                                  formerly
                       China Premium Food Corporation

              Delaware                               62-1681831
   (State or other jurisdiction of                (I.R.S. Employer
   incorporation or organization)                Identification No.)

           11300 US Highway 1, North Palm Beach, Florida 33408 USA
                  (Address of principal executive offices)

                               (561) 625-1411
                        Registrant's telephone number

---------------------------------------------------------------------------
             (Former name, former address and former fiscal year 
                        if changed since last report)


The number of shares outstanding of each of the issuer's classes of common 
stock, as of the latest practicable date is as follows:

      Date                      Class                    Shares Outstanding
      November 10, 2005         Common Stock                141,253,751


Transitional Small Business Disclosure Format (Check One)  YES [ ]   NO [x]


  


BRAVO! FOODS INTERNATIONAL CORP.

TABLE OF CONTENTS

PART I. FINANCIAL INFORMATION

Item 1. Financial statements 

        Consolidated balance sheets as of                         F-1
        September 30, 2005 (unaudited) and December 31, 2004 

        Consolidated statements of operations                     F-3
        (unaudited) for the three and nine months ended
        September 30, 2005 and 2004

        Consolidated statements of cash flows                     F-4
        (unaudited) for the nine months ended
        September 30, 2005 and 2004

        Notes to consolidated financial statements (unaudited)    F-5

Item 2. Management's Discussion and Analysis of Financial          18
         Condition and Results of Operations

Item 3. Controls and Procedures                                    32


PART II - OTHER INFORMATION 

Item 2. Changes in Securities and Use of Proceeds                  33

Item 6. Exhibits                                                   34

SIGNATURES                                                         35

EXHIBITS 


  


              BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARIES

                         CONSOLIDATED BALANCE SHEETS




                                                        September 30,     December 31,
                                                            2005             2004
                                                        -------------     ------------
                                                                  (unaudited)

                                                                    
Assets 

Current assets:
  Cash and cash equivalents                              $   553,857      $   113,888
  Accounts receivable-net                                    201,249           51,968
  Inventories                                                252,829           11,656
  Prepaid expenses                                         1,724,422          551,510
                                                         -----------      -----------

      Total current assets                                 2,732,357          729,022
Furniture and equipment, net                                 173,078          111,206
License rights, net of accumulated amortization              362,285           67,301
Trademarks, net                                               67,958           10,249
Deferred product development costs                           398,226          162,169
Deferred costs Master Distribution Agreement-net          11,800,833                -
Deposits                                                      15,231           13,900
                                                         -----------      -----------

Total assets                                             $15,549,968      $ 1,093,847
                                                         ===========      ===========

Liabilities and Capital Deficit

Current liabilities:
  Note payable to International Paper                    $   187,743      $   187,743
  Note payable to Alpha Capital                              100,000          217,954
  Note payable to Mid-Am Capital LLC                         112,480          111,262
  Note payable to Libra Finance                               43,750           40,106
  Note payable to Longview                                   104,680           54,086
  Note payable to Stonestreet                                      -           47,014
  Note payable to Whalehaven                                       -           17,082
  Note payable to Bi-Coastal                                   6,462           13,649
  Note payable to Gem Funding                                      -            8,231
  Note payable to Warner Brothers                            147,115          147,115
  Note payable to Gamma Capital                                    -           59,678
  Note payable to Momona Capital                                   -           25,885
  Note payable to Ellis International                              -           25,885
  Accounts payable                                         5,617,708        1,763,339
  Accrued liabilities                                        518,273          375,962
                                                         -----------      -----------

      Total current liabilities                            6,838,211        3,094,991
Dividends payable                                          1,167,380          928,379
Other notes payable                                                -          100,171
                                                         -----------      -----------

Total liabilities                                          8,005,591        4,123,541
                                                         ===========      ===========



  F-1


              BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARIES

                         CONSOLIDATED BALANCE SHEETS




                                                        September 30,     December 31,
                                                            2005             2004
                                                        -------------     ------------
                                                                  (unaudited)

                                                                    
Commitments and contingencies

Capital Surplus/Deficit (Note 2): 
  Series B convertible, 9% cumulative and redeemable
   preferred stock, stated value $1.00 per share,
   1,260,000 shares authorized, 107,440 shares issued 
   and outstanding, redeemable at $107,440                   107,440          107,440
  Series F convertible and redeemable preferred stock,
   stated value $10.00 per share, 5,248 and 55,515
   shares issued and outstanding                              48,471          512,740
  Series H convertible, 7% cumulative and redeemable
   preferred stock, stated value $10.00 per share,
   64,500 and 165,500 shares issued and outstanding          349,037          895,591
  Series I convertible, 8% cumulative and redeemable
   preferred stock, stated value $10.00 per share,
   30,000 shares issued and outstanding                            -           72,192
  Series J convertible, 8% cumulative and redeemable
   preferred stock, stated value $10.00 per share,
   200,000 shares issued and outstanding                   1,854,279        1,854,279
  Series K convertible, 8% cumulative and redeemable
   preferred stock, stated value $10.00 per share,
   95,000 shares issued and outstanding                      950,000          950,000
  Common stock, par value $0.001 per share,
   300,000,000 shares authorized, 137,798,337 and
   57,793,501 shares issued and outstanding                  137,798           57,794
  Additional paid-in capital                              45,606,762       26,257,299
  Accumulated deficit                                    (41,485,761)     (33,737,029)
  Translation adjustment                                     (23,649)               -
                                                         -----------      -----------

Total capital surplus/(deficit)                            7,544,377       (3,029,694)
                                                         -----------      -----------

Total liabilities and capital surplus/(deficit)          $15,549,968      $ 1,093,847
                                                         ===========      ===========


                           See accompanying notes.


  F-2


              BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARIES
                    CONSOLIDATED STATEMENTS OF OPERATIONS




                                                      Three Months Ended                 Nine Months Ended
                                                         September 30,                     September 30,
                                                  -----------------------------     -----------------------------
                                                     2005             2004             2005             2004
                                                     ----             ----             ----             ----
                                                  (unaudited)      (unaudited)      (unaudited)      (unaudited)

                                                                                         
Revenue - unit sales                              $  3,245,305     $    747,198     $  6,558,343     $  2,236,383
Revenue - gross kit sales                                    -           78,232           33,350          468,609
                                                  ------------     ------------     ------------     ------------
Total revenue                                        3,245,305          825,430        6,591,693        2,704,992
Cost of sales                                       (2,360,884)        (628,747)      (4,719,011)      (1,893,834)
                                                  ------------     ------------     ------------     ------------
Gross margin                                           884,421          196,683        1,872,682          811,158
Selling expenses                                     1,727,531          652,622        3,525,002        1,270,042
Product development                                     84,690           33,932          194,955           55,104
General and administrative expense                     905,487          551,299        2,345,041        2,213,326
                                                  ------------     ------------     ------------     ------------
Loss from operations                                (1,833,287)      (1,041,170)      (4,192,316)      (2,727,314)
Other (income) expense
  Non-recurring finder's fee                         3,000,000                -        3,000,000                -
  Interest expense                                      73,169           79,822          293,415          154,817
                                                  ------------     ------------     ------------     ------------
Loss before income taxes                            (4,096,456)      (1,120,992)      (7,485,371)      (2,882,131)
Provision for income taxes                                   -                -                -                -
                                                  ------------     ------------     ------------     ------------
Net loss                                            (4,807,289)      (1,120,992)      (7,485,371)      (2,882,131)

Dividends accrued for Series B preferred stock          (2,437)          (2,437)          (7,232)          (7,259)
Dividends accrued for Series G preferred stock               -                -                -          (15,633)
Dividends accrued for Series H preferred stock         (11,434)         (29,201)         (67,857)         (86,967)
Dividends accrued for Series I preferred stock            (460)          (6,049)         (11,397)         (18,017)
Dividends accrued for Series J preferred stock         (49,972)         (40,329)        (119,671)        (120,109)
Dividends accrued for Series K preferred stock         (23,737)         (19,156)         (56,844)         (43,475)
                                                  ------------     ------------     ------------     ------------

Net loss applicable to common shareholders        $ (4,994,496)    $ (1,218,164)    $ (7,748,732)    $ (3,173,591)
                                                  ============     ============     ============     ============

Weighted average number of common shares
 outstanding                                       113,680,645       44,374,877       82,091,556       38,254,305
                                                  ============     ============     ============     ============
Basic and diluted loss per share                  $      (0.04)    $      (0.03)    $      (0.09)    $      (0.08)
                                                  ============     ============     ============     ============
Comprehensive loss and its components
 consist of the following:
  Net loss                                        $ (4,906,456)    $ (1,120,992)    $ (7,485,731)    $ (2,882,131)
  Foreign currency translation adjustment               (5,670)              -           (23,649)               -
                                                  ------------     ------------     ------------     ------------
Comprehensive loss                                $ (4,912,126)    $ (1,120,992)    $ (7,509,380)    $ (2,882,131)
                                                  ============     ============     ============     ============


                           See accompanying notes.


  F-3


              BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARIES
                    CONSOLIDATED STATEMENTS OF CASH FLOWS




                                                                Nine Months Ended September 30
                                                                ------------------------------
                                                                    2005             2004
                                                                    ----             ----
                                                                 (unaudited)      (unaudited)

                                                                           
Cash flows from operating activities:
  Net loss                                                      $(7,485,731)     $(2,882,131)
  Adjustments to reconcile net loss to net cash used
   in operating activities:
    Depreciation and amortization                                   560,646          248,995
    Stock issuance for compensation, finders' fee and
     due diligence fees                                             346,438          116,000
Increase (decrease) from changes in:
  Accounts receivable                                              (149,281)          (8,490)
  Inventories                                                      (241,173)         (20,691)
  Prepaid expenses                                               (1,174,243)        (271,323)
  Accounts payable and accrued expenses                           4,208,414         (224,031)
  Deferred product development costs                             (1,021,518)        (331,169)
                                                                -----------      -----------
Net cash used in operating activities                            (4,956,448)      (3,372,840)
                                                                -----------      -----------

Cash flows from investing activities:
  Purchase of equipment                                             (90,583)         (47,647)
                                                                -----------      -----------
Net cash used in investing activities                               (90,583)         (47,647)
                                                                -----------      -----------

Cash flows from financing activities:
  Proceeds of Series K preferred stock                                    -          950,000
  Proceeds from conversion of warrants                            2,958,509                -
  Convert account payable into note payable                               -        1,128,386
  Convertible notes payable                                       2,350,000        2,639,999
  Private placement financing                                       450,000                -
  Payment of note payable, bank loan and license
   fee payable                                                            -       (1,278,386)
  Redeem warrants                                                  (100,000)               -
  Registration costs for financing                                 (147,860)         (20,108)
                                                                -----------      -----------
Net cash provided by financing activities                         5,510,649        3,419,891
                                                                -----------      -----------

Effect of changes in exchange rates on cash                         (23,649)               -
                                                                -----------      -----------
Net (increase) in cash and cash equivalents                         439,969             (596)
Cash and cash equivalents, beginning of period                      113,888           58,859
                                                                -----------      -----------
Cash and cash equivalents, end of period                        $   553,857      $    58,263
                                                                ===========      ===========


                           See accompanying notes.


  F-4


              BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARIES
                 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                             SEPTEMBER 30, 2005
                                 (UNAUDITED)

Note 1 -Interim Periods

      The accompanying unaudited consolidated financial statements include 
the accounts of Bravo! Foods International Corp. and its wholly owned 
subsidiary Bravo! Brands (UK) Ltd. (collectively the "Company").  The 
Company is engaged in the sale of flavored milk products and flavor 
ingredients in the United States, the United Kingdom and various countries 
in the Middle East and is establishing infrastructures to conduct business 
in Canada.

      The accompanying unaudited consolidated financial statements have 
been prepared in accordance with generally accepted accounting principles 
for interim financial information and with the instructions to Form 10QSB 
and Article 10 of Regulation S-X.  Accordingly, the accompanying financial 
statements do not include all the information and footnotes required by 
generally accepted accounting principles for complete financial statements.  
All significant inter-company accounts and transactions have been 
eliminated in consolidation.  The consolidated financial statements are 
presented in U.S. dollars.  In the opinion of management, all adjustments 
(consisting of normal recurring adjustments) considered necessary for a 
fair presentation have been included.  Operating results for the period 
ended September 30, 2005 are not necessarily indicative of the results that 
may be expected for the year ending December 31, 2005.  For further 
information, refer to the consolidated financial statements and footnotes 
thereto included in the Company's annual report for the year ended December 
31, 2004.

      As shown in the accompanying consolidated financial statements, the 
Company has suffered operating losses and negative cash flow from 
operations since inception and has an accumulated deficit of $41,485,671, 
negative working capital of $4,105,854 and is delinquent on certain of its 
debts at September 30, 2005.  Further, the Company's auditors stated in their 
report on the Company's Consolidated Financial Statements for the year ended 
December 31, 2004, that these conditions raise substantial doubt about the 
Company's ability to continue as a going concern.  Management plans to 
increase gross profit margins in its U.S. business, grow its international 
business, obtain additional financing and launch one new product line in the 
fourth quarter of 2005.  While there is no assurance that funding will be 
available or that the Company will be able to improve its profit margins, the 
Company is continuing to actively seek equity and/or debt financing and, in 
January 2005, obtained financing of $2,350,000, with $1,950,000 invested in 
the six months ending June 30, 2005 and the balance invested in August 2005.

      On July 13, 2005, Coca-Cola Enterprises Inc. (CCE) acquired options 
to purchase shares of common stock, convertible securities and warrants, 
entitling Coca-Cola Enterprises to purchase approximately 69,000,000 shares 
of common stock from 9 non-affiliated shareholders of the Company (the 
"Options"), representing approximately 23% of the authorized shares of the 
Company's common stock.  Coca-Cola Enterprises and the Company 
contemporaneously commenced negotiations regarding a stock purchase 
agreement for the direct sale of approximately 81 million shares of the 
Company's common stock to Coca-Cola Enterprises.  The consummation of the 
direct sale and the exercise of the Options by Coca-Cola Enterprises would 
have resulted in 


  F-5


              BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARIES
                 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                             SEPTEMBER 30, 2005
                                 (UNAUDITED)

Coca-Cola Enterprises holding slightly in excess of 50% of the Company's 
equity on a fully diluted basis.  These transactions were contingent upon 
the execution of a Master Distribution Agreement between the Company and 
Coca-Cola Enterprises.  On July 29, 2005, the Company and Coca-Cola 
Enterprises entered into a Letter of Intent memorializing and confirming 
their intention to enter into the stock purchase agreement. 

      Subsequent to the execution of the Letter of Intent, in lieu of the 
exercise of the Options and the stock purchase agreement, the parties 
agreed to enter into the Master Distribution Agreement with the attendant 
grant of three year warrants by the Company to Coca-Cola Enterprises for 
the right to purchase 30 million shares of the Company's common stock at an 
exercise price of $0.36 per share.  On August 31, 2005, the Company issued 
the warrants to Coca-Cola Enterprises, and the parties executed a ten year 
exclusive Master Distribution Agreement that will significantly expand the 
distribution and sales of the Company's products.  The Company presently is 
seeking from $10 - $15 million in new financing to promote the expanded 
sales anticipated with the implementation of the Master Distribution 
Agreement and for general working capital.

      The Company recorded a $3,000,000 one time, non-recurring finder's 
fee payable to a third party in connection with the execution of the Master 
Distribution Agreement with Coca-Cola Enterprises, Inc. in the quarter ending 
September 30, 2005. In addition, the Company recorded $99,168, pro-rata, of an 
$11,900,000 net charge in deferred distribution costs for the issuance of a 
three year warrant to Coca-Cola Enterprises to purchase of 30,000,000 shares 
of our common stock in connection with the execution of the Master 
Distribution Agreement. The Company will recognize that cost as a selling 
expense over the 10-year term of the Master Distribution Agreement.

      No assurances can be given that the Company will be successful in 
carrying out its plans.  The consolidated financial statements do not 
include any adjustments that might result from the outcome of this 
uncertainty.

Revenue Recognition

      The Company recognizes revenue in the United States at the gross 
amount of its invoices for the sale of finished product to wholesale 
buyers.  Commencing with the first quarter 2004, the Company no longer uses 
the sale of "kits" as a revenue event in the United States.  Rather, the 
Company takes title to its branded flavored milks when they are shipped by 
the Company's third party processors and recognize as revenue the gross 
wholesale price charged to the Company's wholesale customers.  Expenses for 
slotting fees and certain promotions are treated as a reduction of reported 
revenue.  The Company determines gross margin by deducting from the 
reported wholesale price the cost charged by the Company's third party 
processors to produce the branded milk products.  The sale of "kits" will 
remain as the revenue model for the Company's international business, with 
the exception of the United Kingdom and Canada, where the domestic business 
model will be implemented.

      The Company recognizes revenue for its international business at the 
gross amount of its invoices for the sale of flavor ingredients and 
production rights (collectively referred to as "kits") at the time of 
shipment of flavor ingredients to processor dairies with whom the Company 
has production contracts for extended shelf life and aseptic long life 
milk.  The Company recognizes revenue based upon its role as the principal 
in these transactions, its discretion in establishing kit prices (including 
the price of flavor ingredients and production rights fees), its 
development and refinement of flavors and flavor modifications, its 
discretion in supplier selection and its credit risk to pay for ingredients 
if processors do not pay ingredient suppliers.  The revenue generated by 
the production contracts under this model is allocated for the processors' 
purchase of flavor 


  F-6


              BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARIES
                 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                             SEPTEMBER 30, 2005
                                 (UNAUDITED)

ingredients and fees charged by the Company to the processors for 
production rights.  The Company formulates the price of production rights 
to cover its royalties under intellectual property licenses, which varies 
by licensor as a percentage of the total cost of a kit sold to the 
processor dairy under the production agreement.  The Company recognizes 
revenue on the gross amount of "kit" invoices to the dairy processors and 
simultaneously records as cost of goods sold the cost of flavor ingredients 
paid by the processor dairies to ingredients suppliers.  The recognition of 
revenue generated from the sale of production rights associated with the 
flavor ingredients is complete upon shipment of the ingredients to the 
processor, given the short utilization cycle of the ingredients shipped.  
The criteria to meet this guideline are: 1) persuasive evidence that an 
arrangement exists, 2) delivery has occurred or services have been 
rendered, 3) the price to the buyer is fixed or determinable and 4) 
collectibility is reasonably assured.

      The Company follows the final consensus reached by the Emerging 
Issues Task Force (EITF) 99-19, "Reporting Revenue Gross as a Principal 
versus Net as an Agent".  In certain circumstances in its U.S. business, 
the Company is required to pay slotting fees, give promotional discounts or 
make marketing allowances in order to secure wholesale customers.  These 
payments, discounts and allowances reduce the Company's reported revenue in 
accordance with the guidelines set forth in EITF 01-9 and SEC Staff 
Accounting Bulletin No. 104.  Pursuant to EITF 99-19, international sales 
of kits made directly to customers by the Company are reflected in the 
statements of operations on a gross basis, whereby the total amount billed 
to the customer is recognized as revenue.  

Stock-based Compensation

      The Company has adopted the intrinsic value method of accounting for 
employee stock options as permitted by Statement of Financial Accounting 
Standards No. 123, "Accounting for Stock-based Compensation" (SFAS No. 123) 
and discloses the pro forma effect on net loss and loss per share as if the 
fair value based method had been applied.  For equity instruments, 
including stock options issued to non-employees, the fair value of the 
equity instruments or the fair value of the consideration received, 
whichever is more readily determinable, is used to determine the value of 
services or goods received and the corresponding charge to operations. 

      On April 6, 2005, the Company's Board of Directors voted to adopt a 
Stock Incentive Plan for the issuance of incentive options for up to 
10,397,745 shares of the Company's common stock to management, employees 
and certain key third party service providers.  On May 12, 2005, the Board 
received and reviewed a Report of the Compensation Committee recommending 
an allocation schedule for the allotted incentive option shares and voted 
to implement the Stock Incentive Plan for distribution of such options to 
the Corporation's present management, employees, directors and service 
providers as set forth in the Compensation Committee Report. The Company 
has not as yet issued the Incentive Stock Option Grant contracts.


  F-7


              BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARIES
                 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                             SEPTEMBER 30, 2005
                                 (UNAUDITED)

Note 2 - Transactions in Capital Surplus/Deficit

      Quarter Ending March 31, 2005
      -----------------------------

      New Financing: January 2005 Convertible Notes.  On January 31, 2005, 
we closed a funding transaction with Longview Fund, LP, Longview Equity 
Fund, LP, Longview International Equity Fund, LP, Alpha Capital 
Aktiengesellschaft and Whalehaven Funds Limited, five institutional 
accredited investors, for the issuance and sale to the Subscribers of up to 
$2,300,000 of principal amount of promissory notes convertible into shares 
of our common stock, and Warrants to purchase shares of common stock at 
100% coverage of the common stock issuable in accordance with the principal 
amount of the notes.  One Million One Hundred Fifty Thousand Dollars 
($1,150,000) of the purchase price was paid on the initial closing date, 
and One Million One Hundred Fifty Thousand Dollars ($1,150,000) of the 
purchase price will be payable within five (5) business days after the 
actual effectiveness of an SB-2 Registration Statement as defined in the 
Subscription Agreement.  The initial closing notes were at prime plus 4% 
interest in the aggregate amount of $1,150,000, plus five-year Warrants for 
the purchase of, in the aggregate, 9,200,000 shares of common stock, at the 
lesser of (i) $0.16, or (ii) 101% of the closing bid price of the Common 
Stock as reported by Bloomberg L.P. for the OTC Bulletin Board for the 
trading day preceding the Closing Date.  The notes are convertible into 
shares of our common stock at $0.125 per common share.  Conversions are 
limited to a maximum ownership of 9.99% of the underlying common stock at 
any one time.  The notes have a maturity date two years from closing and 
are payable in twelve equal monthly installments, commencing June 1, 2005.  
The installment payments consist of principal equal to 1/20th of the initial 
principal amount which, subject to certain conditions concerning trading 
volume and price, can be paid in cash at 103% of the monthly installment, 
or common stock or a combination of both.  The notes have an acceleration 
provision upon the change in a majority of the present Board of Directors 
except as the result of the death of one or more directors, or a change in 
the present CEO.  In connection with this transaction, we issued restricted 
common stock in the aggregate amount of 460,000 shares plus the aggregate 
cash amount of $57,500 for due diligence fees to the investors in this 
transaction.  We issued the Convertible Promissory Note and the underlying 
common stock upon conversion to an accredited investor, pursuant to a 
Regulation D offering.  The underlying common stock is now registered 
pursuant to a Form SB-2 registration statement declared effective August 2, 
2005.

      November 2003 Convertible Notes.  We converted $25,000 of our 
November 2003 Convertible Promissory Notes into 549,340 shares of common 
stock pursuant to a notice of conversion from Gamma Opportunity Capital 
Partners LP, at a fixed conversion price of $0.05.  The conversion included 
$2,467 of accrued and unpaid interest on the converted amount.  We issued 
the underlying common stock upon conversion pursuant to a Form SB-2 
registration statement, declared effective on August 3, 2004.

      April 2004 Convertible Notes.  We converted $99,999 of our April 2004 
Convertible Promissory Notes into 1,141,387 shares of common stock pursuant 
to notices of conversion from Longview Fund LP, at a fixed conversion price 
of $0.10.  The conversions included $14,138 of 


  F-8


              BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARIES
                 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                             SEPTEMBER 30, 2005
                                 (UNAUDITED)

accrued and unpaid interest.  We issued the underlying common stock upon 
conversion pursuant to our SB-2 registration statement, declared effective 
on August 3, 2004.

      June 2004 Convertible Notes.  We converted $41,666 of our June 2004 
Convertible Promissory Notes into 430,327 shares of restricted common stock 
pursuant to a notice of conversion from Longview Fund LP, at a fixed 
conversion price of $0.15.  The conversion included $22,822 of accrued and 
unpaid interest.  We issued the Convertible Promissory Note and the 
underlying common stock upon conversion to an accredited investor, pursuant 
to a Regulation D offering.  The underlying common stock is now registered 
pursuant to a Form SB-2 registration statement declared effective April 18, 
2005.

      Quarter Ending June 30, 2005
      ----------------------------

      New Financing: April 2005 Convertible Note.  On April 21, 2005, we 
closed a funding transaction with Alpha Capital Aktiengesellschaft for the 
issuance of a convertible 10% note in the aggregate amount of $300,000.  
The promissory note is convertible into shares of common stock of the 
Company at $0.20 per common share.  Conversions are limited to a maximum 
ownership of 9.99% of the Company's common stock at any one time.  The note 
has an October 31, 2005 maturity and is payable in five equal monthly 
installments, commencing June 1, 2005.  The installment payments consist of 
principal (equal to 1/5th of the initial principal amount) plus accrued 
interest.  Installments can be paid in cash or common stock valued at the 
average closing price of the Company's common stock during the five trading 
days immediately preceding the relevant installment due date.  The Company 
has repriced Class B Warrants issued on June 30, 2004 from $2.00 per share 
to $0.125 per share and issued restricted common stock in the aggregate 
amount of 93,750 shares for finder's fees to a third-party to facilitate 
this transaction.  The Company has the right to prepay the promissory note 
by paying to the holder cash equal to 120% of the principal to be prepaid 
plus accrued interest.  The notes have an acceleration provision upon the 
change in a majority of the present Board of Directors except as the result 
of the death of one or more directors or a change in the present CEO of the 
Company.  The common stock underlying the note and the finder's fee common 
stock have "piggy back" registration rights.  We issued the convertible 
note and finder's fee common stock to accredited investors, pursuant to a 
Regulation D offering.

      New Financing: May 2005 Convertible Notes.  On May 23, 2005, we 
closed a funding transaction (the "May '05 Transaction") with Longview 
Fund, LP, Whalehaven Funds Limited, Ellis International Ltd., and Osher 
Capital Corp., four institutional accredited investors, for the issuance 
and sale to the Subscribers of Five Hundred Thousand Dollars ($500,000) of 
principal amount of promissory notes convertible into shares of our common 
stock and Warrants to purchase shares of common stock at 100% coverage of 
the common stock issuable in accordance with the principal amount of the 
notes.  This May '05 Transaction was a part of a January 23, 2005 funding 
transaction for an aggregate of Two Million Three Hundred Thousand Dollars 
($2,300,000), One Million One Hundred Fifty Thousand Dollars ($1,150,000) 
of which was paid on the initial closing date, and One Million One Hundred 
Fifty Thousand Dollars ($1,150,000) of which (the "Second Tranche") was to 
be payable within five (5) business days after the actual 


  F-9


              BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARIES
                 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                             SEPTEMBER 30, 2005
                                 (UNAUDITED)

effectiveness of an SB-2 Registration Statement covering the aggregate 
transaction, as defined in the Subscription Agreement.  The May '05 
Transaction for Five Hundred Thousand Dollars ($500,000) is a partial 
interim closing of the Second Tranche, which occurred prior to the 
anticipated effectiveness of the SB-2 Registration Statement covering the 
aggregate transaction.  Contemporaneous with the May '05 Transaction, we 
agreed to a modification of the January 23, 2005 aggregate transaction for 
the substitution of Ellis International Ltd. and Osher Capital Corp. in the 
place of Alpha Capital Aktiengesellschaft, one of the original investors.  
The May '05 Transaction convertible notes are at prime plus 4% interest in 
the aggregate amount of $500,000, plus five-year Warrants for the purchase 
of, in the aggregate, 4,000,000 shares of common stock, at an exercise 
price of $0.129.  The notes are convertible into shares of our common stock 
at $0.125 per common share.  Conversions are limited to a maximum ownership 
of 9.99% of the underlying common stock at any one time.  The notes have a 
maturity date two years from closing and are payable in twelve equal 
monthly installments, commencing June 1, 2005.  The installment payments 
consist of principal equal to 1/20th of the initial principal amount which, 
subject to certain conditions concerning trading volume and price, can be 
paid in cash at 103% of the monthly installment or common stock or a 
combination of both.  The notes have an acceleration provision upon the 
change in a majority of the present Board of Directors except as the result 
of the death of one or more directors, or a change in the present CEO.  In 
connection with this transaction, we issued restricted common stock in the 
aggregate amount of 200,000 shares plus the aggregate cash amount of 
$25,000 for due diligence fees to Longview Fund, LP, Gem Funding LLC, Ellis 
International Ltd., and Osher Capital Corp. in this transaction.  The 
Second Tranche of the January 23, 2005 aggregate transaction, now in the 
amount of $650,000, remains outstanding and will be triggered by the 
effectiveness of the pending SB-2 registration statement.

      Conversions: November 2003 Convertible Notes.  We converted $50,000 
of our November 2003 Convertible Promissory Note into 1,106,740 shares of 
common stock pursuant to a notice of conversion from Gamma Opportunity 
Capital Partners LP, at a fixed conversion price of $0.05.  The conversion 
included $5,337 of accrued and unpaid interest.  We issued the underlying 
common stock upon conversion pursuant to a Form SB-2 registration 
statement, declared effective on August 3, 2004.

      Warrant Exercise: November 2003 Warrant.  We issued 1,000,000 shares 
of common stock to Gamma Opportunity Capital Partners LP pursuant to the 
exercise of a Warrant issued in connection with the November 2003 financing 
transaction, and received $50,000 in warrant exercise payments.  The shares 
of common stock underlying the warrant were issued pursuant to a Form SB-2 
shelf registration statement, declared effective by the SEC on August 3, 
2004.

      Warrant Exercise: April 2004 Warrant.  We issued 1,500,000 shares of 
common stock to Longview Fund LP pursuant to the exercise of a Warrant 
issued in connection with the April 2004 financing transaction, and 
received $225,000 in warrant exercise payments.  The shares of common stock 
underlying the warrant were issued pursuant to a Form SB-2 shelf 
registration statement, declared effective by the SEC on August 3, 2004.


  F-10


              BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARIES
                 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                             SEPTEMBER 30, 2005
                                 (UNAUDITED)

      Conversions: June 2004 Convertible Notes.  We converted $528,573 of 
our June 2004 Convertible Promissory Notes into 5,633,039 shares of common 
stock pursuant to notices of conversion from Longview Fund LP, Gem Funding 
LLC, Whalehaven Capital Fund Limited, Stonestreet Limited Partnership and 
Bi-Coastal Consulting Corp. at a fixed conversion price of $0.10.  The 
conversion included $33,689 of accrued and unpaid interest.  We issued the 
common stock upon conversion pursuant to a Form SB-2 registration statement 
declared effective by the Securities and Exchange Commission on April 18, 
2005.

      Warrant Exercise: June 2004 Warrant.  We issued 2,200,000 shares of 
common stock to Longview Fund LP, Whalehaven Capital Fund Limited and 
Stonestreet Limited Partnership pursuant to the exercise of Warrants issued 
in connection with the June 2004 financing transaction, and received 
$309,000 in warrant exercise payments.  The shares of common stock 
underlying the warrants were issued pursuant to a Form SB-2 shelf 
registration statement, declared effective by the SEC on April 18, 2005.

      Conversions: October 2004 Convertible Notes.  We converted $446,250 
of our October 2004 Convertible Promissory Notes into 4,718,514 shares of 
common stock pursuant to notices of conversion from Longview Fund LP, Gem 
Funding LLC, Whalehaven Capital Fund Limited, Stonestreet Limited 
Partnership and Bi-Coastal Consulting Corp. at a fixed conversion price of 
$0.10.  The conversion included $25,602 of accrued and unpaid interest.  We 
issued the common stock upon conversion pursuant to a Form SB-2 
registration statement declared effective by the Securities and Exchange 
Commission on April 18, 2005.

      Warrant Exercise: October 2004 Warrant.  We issued 1,700,000 shares 
of common stock to Longview Fund LP, Whalehaven Capital Fund Limited and 
Stonestreet Limited Partnership pursuant to the exercise of Warrants issued 
in connection with the October 2004 financing transaction, and received 
$248,700 in warrant exercise payments.  The shares of common stock 
underlying the warrants were issued pursuant to a Form SB-2 shelf 
registration statement, declared effective by the SEC on April 18, 2005.

      Conversions: December 2004 Convertible Notes.  We converted $210,000 
of our December 2004 Convertible Promissory Notes into 2,176,706 shares of 
common stock pursuant to notices of conversion, to Momona Capital Corp. and 
Ellis International Ltd Inc., at a fixed conversion price of $0.10 per 
share.  The conversion included $7,450 of accrued and unpaid interest.  We 
issued the underlying common stock upon conversion pursuant to a Form SB-2 
registration statement, declared effective on April 18, 2005.

      Warrant Exercise: December 2004 Warrant.  We issued 500,000 shares of 
common stock to Momona Capital Corp. and Ellis International Ltd Inc., 
pursuant to the exercise of Warrants issued in connection with the December 
2004 financing transaction, and received $72,500 in warrant exercise 
payments.  The shares of common stock underlying the warrants were issued 
pursuant to a Form SB-2 shelf registration statement, declared effective by 
the SEC on April 18, 2005.


  F-11


              BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARIES
                 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                             SEPTEMBER 30, 2005
                                 (UNAUDITED)

      Conversions: January 2005 Convertible Notes.  We converted $534,304 
of our January 2005 Convertible Promissory Notes into 4,461,685 shares of 
restricted common stock pursuant to notices of conversion, to Longview Fund 
LP, Longview Equity Fund LP and Longview International Equity Fund LP at a 
fixed conversion price of $0.125 per share.  We issued the Convertible 
Promissory Note and the underlying common stock upon conversion to an 
accredited investor, pursuant to a Regulation D offering.  The underlying 
common stock is now registered pursuant to a Form SB-2 registration 
statement declared effective August 2, 2005.

      Conversions: Series F Convertible Preferred.  We converted 31,134 
shares of our Series F Convertible Preferred, having a stated value of 
$311,340 into 2,903,839 shares of common stock pursuant to notices of 
conversion, to Austinvest Anstalt Balzers and Esquire Trade & Finance Inc.  
We issued the Series F Convertible Preferred and the underlying common 
stock upon conversion to accredited investors, pursuant to a Regulation D 
offering and Rule 144(k).  

      Conversions: Series H Convertible Preferred.  We converted 100,000 
shares of our Series H Convertible Preferred, having a stated value of 
$1,000,000 into 2,500,000 shares of common stock pursuant to notices of 
conversion, to four individual and two institutional investors.  We issued 
the Convertible Preferred and the underlying common stock upon conversion 
to accredited investors, pursuant to a Regulation D offering and Rule 
144(k).  

      Conversions: Series I Convertible Preferred.  We converted 20,000 
shares of our Series I Convertible Preferred, having a stated value of 
$200,000 into 2,354,808 shares of common stock pursuant to a notice of 
conversion, to Alpha Capital AG.  We issued the Convertible Preferred and 
the underlying common stock upon conversion to accredited investors, 
pursuant to a Regulation D offering and Rule 144(k).  

      Warrant Exercise: Series I Warrant.  We issued 1,333,333 shares of 
restricted common stock to Alpha Capital AG, pursuant to the exercise of 
Warrants issued in connection with the Series I financing transaction, and 
received $133,333 in warrant exercise payments.  The shares of common stock 
underlying the warrants are now registered pursuant to a Form SB-2 shelf 
registration statement, declared effective by the SEC on August 2, 2005.

      Private Placements. On May 17, 2005 we issued the aggregate of 27,500 
restricted shares of the Company's common stock, with a recorded value of 
$4,950, to eleven product sales brokers as a bonus for the performance of 
services for the Company.  We issued the restricted common stock pursuant to 
Section 4(6) of the Securities Act of 1933, which provides an exemption from 
the registration requirements of the Act for transactions not involving a 
public offering.

      S-8 Registration. On April 14, 2005 and April 18, 2005, we issued 
750,000 and 250,000 shares, respectively, of our common stock to Geoffrey 
Eiten, for services rendered for strategic business planning.  These shares 
were part of 1,500,000 shares of the Company's common stock registered 
under a Form S-8 registration statement filed December 23, 2004.


  F-12


              BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARIES
                 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                             SEPTEMBER 30, 2005
                                 (UNAUDITED)

      Warrant Issue.  On June 20, 2005, we issued one year Warrant to 
Marvel Enterprises Inc. to purchase 1,000,000 shares of our common stock a 
$0.05 per share.  This Warrant was issued in connection with the execution 
of a License Agreement with Marvel for the United States, Canada and 
Mexico.  We issued the Warrant pursuant to Section 4(6) of the Securities 
Act of 1933, which provides an exemption from the registration requirements 
of the Act for transactions not involving a public offering.

      Quarter Ending September 30, 2005
      ---------------------------------

      Warrant Exercise: Series D Warrant.  We issued 696,042 shares of 
common stock to Longview Fund LP, Longview Equity Fund LP, Longview 
International Equity Fund LP and Esquire Trade & Finance Inc., pursuant to 
the cashless exercises of warrants for 763,750 shares of common stock. We 
issued the Warrants and the underlying common stock upon exercise to 
accredited investors, pursuant to a Regulation D offering and Rule 144(k).

      Conversions: Series F Convertible Preferred.  We converted 19,133 
shares of our Series F Convertible Preferred, having a stated value of 
$191,330 into 804,752 shares of common stock pursuant to notices of 
conversion to Amro International, SA.  We issued the Series F Convertible 
Preferred and the underlying common stock upon conversion to accredited 
investors, pursuant to a Regulation D offering and Rule 144(k).  

      Warrant Exercise: Series F Warrant.  We issued 3,345,417 shares of 
common stock to Austinvest Anstalt Balzers and Esquire Trade & Finance Inc. 
and Libra Finance, SA., pursuant to the cashless exercise of warrants for 
3,676,518 shares of common stock. We issued the Warrants and the underlying 
common stock upon exercise to accredited investors, pursuant to a 
Regulation D offering and Rule 144(k).

      Conversions: Series H Convertible Preferred.  We converted 1,000 
shares of our Series H Convertible Preferred, having a stated value of 
$10,000 into 25,000 shares of common stock pursuant to notices of 
conversion, to one individual investor.  We issued the Convertible 
Preferred and the underlying common stock upon conversion to accredited 
investors, pursuant to a Regulation D offering and Rule 144(k).  

      Conversions: Series I Convertible Preferred.  We converted 10,000 
shares of our Series I Convertible Preferred, having a stated value of 
$100,000 into 656,953 shares of common stock pursuant to a notice of 
conversion, to Tradersbloom Limited.  The conversion included $24,000 of 
accrued and unpaid interest.  We issued the Convertible Preferred and the 
underlying common stock upon conversion to accredited investors, pursuant 
to a Regulation D offering and Rule 144(k).  

      Conversions: April 2004 Convertible Notes.  We converted $250,000 of 
our April 2004 Convertible Promissory Notes into 2,808,219 shares of common 
stock pursuant to notices of conversion from Osher Capital Inc., Ellis 
International Ltd Inc. and Alpha Capital AG.  The conversion included 
$3,082 of accrued and unpaid interest on the converted amount.  We issued 


  F-13


              BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARIES
                 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                             SEPTEMBER 30, 2005
                                 (UNAUDITED)

the underlying common stock upon conversion pursuant to a Form SB-2 
registration statement, declared effective on August 4, 2004.

      Conversions: June 2004 Convertible Notes.  We converted $250,000 of 
our June 2004 Convertible Promissory Notes into 2,796,575 shares of common 
stock pursuant to notices of conversion from Alpha Capital AG at a fixed 
conversion price of $0.10.  The conversion included $29,657 of accrued 
and unpaid interest on the converted amount.  We issued the common stock 
upon conversion pursuant to a Form SB-2 registration statement declared 
effective by the Securities and Exchange Commission on April 18, 2005.

      Conversions: October 2004 Convertible Notes.  We converted $125,000 
of our October 2004 Convertible Promissory Notes into 1,342,808 shares of 
common stock pursuant to notices of conversion from Alpha Capital AG at a 
fixed conversion price of $0.10.  The conversion included $9,280 of accrued 
and unpaid interest on the converted amount.  We issued the common stock 
upon conversion pursuant to a Form SB-2 registration statement declared 
effective by the Securities and Exchange Commission on April 18, 2005.

      Warrant Exercise: December 2004 Warrant.  We issued 300,000 shares of 
common stock to Momona Capital Corp. pursuant to the exercise of Warrants 
issued in connection with the December 2004 financing transaction, and 
received $30,000 in warrant exercise payments.  The shares of common stock 
underlying the warrants were issued pursuant to a Form SB-2 shelf 
registration statement, declared effective by the SEC on April 18, 2005.

      Conversions: January 2005 Convertible Notes.  We converted 
$500,071 of our January 2005 Convertible Promissory Notes into 4,186,644 
shares of restricted common stock pursuant to notices of conversion, to 
Longview Fund LP, Longview Equity Fund LP and Longview International Equity 
Fund LP at a fixed conversion price of $0.125 per share.  The conversion 
included $23,260 of accrued and unpaid interest on the converted amount.  
We issued the common stock upon conversion pursuant to a Form SB-2 
registration statement declared effective by the Securities and Exchange 
Commission on August 2, 2005.

      Warrant Exercise: January 2005 Warrant.  We issued 7,200,000 shares 
of common stock to Whalehaven Capital Fund Limited, Longview Fund LP, 
Longview Equity Fund LP and Longview International Equity Fund LP pursuant 
to the exercise of Warrants issued in connection with the January 2005 
financing transaction, and received $720,000 in warrant exercise payments.  
The shares of common stock underlying the warrants were issued pursuant to 
a Form SB-2 shelf registration statement, declared effective by the SEC on 
August 2, 2005.

      Conversions: April 2005 Convertible Notes.  We converted $300,000 of 
our April 2005 Convertible Promissory Note into 1,556,438 shares of 
restricted common stock pursuant to notices of conversion, to Alpha Capital 
AG at a fixed conversion price of $0.20 per share.  The conversion included 
$11,288 of accrued and unpaid interest on the converted amount.  We issued 
the common stock upon conversion pursuant to a Form SB-2 registration 
statement declared effective by the Securities and Exchange Commission 
on August 2, 2005.


  F-14


              BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARIES
                 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                             SEPTEMBER 30, 2005
                                 (UNAUDITED)

      Conversions: May 2005 Convertible Notes.  We converted $475,000 of 
our May 2005 Convertible Promissory Notes into 4,141,270 shares of 
restricted common stock pursuant to notices of conversion, to Whalehaven 
Capital Fund Limited, Ellis International Ltd, Longview Fund LP and Osher 
Capital Corp.  The conversion included $9,317 of accrued and unpaid 
interest on the converted amount.  We issued the common stock upon 
conversion pursuant to a Form SB-2 registration statement declared 
effective by the Securities and Exchange Commission on August 2, 2005.

      Warrant Exercise: May 2005 Warrant.  We issued 4,000,000 shares of 
common stock to Whalehaven Capital Fund Limited, Ellis International Ltd, 
Longview Fund LP and Osher Capital Corp. pursuant to the exercise of 
Warrants issued in connection with the January 2005 financing transaction, 
and received $400,000 in warrant exercise payments.  The shares of common 
stock underlying the warrants were issued pursuant to a Form SB-2 shelf 
registration statement, declared effective by the SEC on August 2, 2005.

      New Financing: August 2005 Convertible Notes.  On August 18, 2005, we 
closed a funding transaction (the "August '05 Transaction") with Longview 
Fund, LP, Longview Equity Fund, LP and Longview International Equity Fund, 
LP, three institutional accredited investors, for the issuance and sale to 
the Subscribers of Six Hundred Fifty Thousand Dollars ($650,000) of 
principal amount of promissory notes convertible into shares of our common 
stock and Warrants to purchase shares of common stock at 100% coverage of 
the common stock issuable in accordance with the principal amount of the 
notes.  This August'05 Transaction was a part of a January 23, 2005 funding 
transaction for an aggregate of Two Million Three Hundred Thousand Dollars 
($2,300,000).  The August '05 Transaction is the Second Tranche of the 
January '05 transaction, which occurred upon the effectiveness of the SB-2 
Registration Statement covering the aggregate transaction.  The August'05 
Transaction convertible notes are at prime plus 4% interest in the 
aggregate amount of $650,000, plus five-year Warrants for the purchase of, 
in the aggregate, 5,200,000 shares of common stock, at an exercise price of 
$0.129.  The notes are convertible into shares of our common stock at 
$0.125 per common share.  Conversions are limited to a maximum ownership of 
9.99% of the underlying common stock at any one time.  The notes have a 
maturity date two years from closing and are payable in twelve equal 
monthly installments.  The installment payments consist of principal equal 
to 1/20th of the initial principal amount which, subject to certain 
conditions concerning trading volume and price, can be paid in cash at 103% 
of the monthly installment, or common stock or a combination of both.  The 
notes have an acceleration provision upon the change in a majority of the 
present Board of Directors except as the result of the death of one or more 
directors, or a change in the present CEO.  In connection with this 
transaction, we issued restricted common stock in the aggregate amount of 
260,000 shares plus the aggregate cash amount of $32,500 for due diligence 
fees to Longview Fund companies.  We issued the equity equivalents, the 
underlying common stock upon conversion and the finders' fee common stock 
pursuant to a Form SB-2 registration statement declared effective by the 
Securities and Exchange Commission on August 2, 2005.


  F-15


              BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARIES
                 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                             SEPTEMBER 30, 2005
                                 (UNAUDITED)

      On September 30, 2005, we repaid $250,000 of the aggregate $650,000 
of the August '05 Transaction notes, as follows: $57,692 to Longview Fund, 
LP,  $144,231 to Longview Equity Fund, LP and $ $48,077 to Longview 
International Equity Fund, LP.  The holders of these notes waived the 
prepayment premium in lieu of their retention of warrants attached to 
August '05 Transaction.

      Conversions: August 2005 Convertible Notes.  We converted $91,217 
of our August 2005 Convertible Promissory Notes into 743,750 shares of 
restricted common stock pursuant to a notice of conversion, to Longview 
Fund LP, at a fixed conversion price of $0.125 per share.  The conversion 
included $1,752 of accrued and unpaid interest on the converted amount.  
We issued the common stock upon conversion pursuant to a Form SB-2 
registration statement declared effective by the Securities and Exchange 
Commission on August 2, 2005.

      Warrant Exercise: August 2005 Warrant.  We issued 5,200,000 shares of 
common stock to Longview Fund LP, Longview Equity Fund LP and Longview 
International Equity Fund LP pursuant to the exercise of Warrants issued in 
connection with the August 2005 financing transaction, and received 
$520,000 in warrant exercise payments.  The shares of common stock 
underlying the warrants were issued pursuant to a Form SB-2 shelf 
registration statement, declared effective by the SEC on August 2, 2005.

      Private Placements.  On August 3, 2005 we issued 500,000 restricted 
shares of our common stock to Geoffrey Eiten, for services rendered for 
strategic business planning.  We issued the restricted common stock 
pursuant to Section 4(6) of the Securities Act of 1933, which provides an 
exemption from the registration requirements of the Act for transactions 
not involving a public offering.

      On August 29 and September 19, 2005 we issued the aggregate of 
1,000,000 restricted shares of our common stock to National Financial 
Communications Corp. pursuant to the exercise of Warrants issued in 
connection with a consulting agreement for services rendered for strategic 
business planning.  We issued the restricted common stock pursuant to 
Section 4(6) of the Securities Act of 1933, which provides an exemption 
from the registration requirements of the Act for transactions not 
involving a public offering.

      On September 19, 2005, we issued 450,000 restricted shares of our 
common stock to Alpha Capital AG, an accredited investor, in a sale not 
involving a public offering at a price of $1.00 per share.  We issued the 
common stock pursuant to a Regulation D offering. 

      Warrant Issue.  On August 31, 2005, we issued a three year Warrant to 
Coca-Cola Enterprises Inc. to purchase 30,000,000 shares of our common 
stock a $0.36 per share.  During the first 18 months of the exercise 
period, the Company has the option to "call" the exercise of up to 
10,000,000 shares of common stock issuable upon exercise of the Warrant, 
upon the Company's satisfaction of certain conditions, including a trading 
price of not less than $1.08 per share for 20 consecutive trading days.  
This Warrant was issued in connection with the execution of a Master 
Distribution Agreement on August 31, 2005.  We issued the Warrant pursuant 
to


  F-16


              BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARIES
                 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                             SEPTEMBER 30, 2005
                                 (UNAUDITED)

Section 4(6) of the Securities Act of 1933, which provides an exemption 
from the registration requirements of the Act for transactions not 
involving a public offering. The Company will record and $11,900,000 net 
charge in deferred distribution costs for the issuance of a three year 
warrant to Coca-Cola Enterprises to purchase of 30,000,000 shares of our 
common stock in connection with the Master Distribution Agreement. The 
Company will recognize that cost as a selling expense over the 10-year 
term of the agreement.


Note 3 - Business Segment and Geographic Information 

      The Company operates principally in the single serve flavored milk 
industry segment, under two distinct business models.  In the United 
States, the Company is responsible for the sale of finished Slammers(R) 
flavored milk (referred to as "unit sales") to retail outlets.  For these 
unit sales, the Company recognizes as revenue the invoiced wholesale prices 
that the Company charges to the retail outlets that purchase the 
Slammers(R) flavored milks.  In countries other than the United States, the 
Company's revenue generally is generated by the sale of kits to dairy 
processors.  Each kit consists of flavor ingredients for the Company's 
Slammers(R) flavored milks and production rights to manufacture and sell 
the milks.  In line with the Company's revenue recognition policies, the 
Company recognizes the full invoiced kit price as revenue. In earlier periods, 
the Company reported the sale of kits to SADAFCO, a third party dairy 
processor located in Saudi Arabia, for distribution to nine Middle Eastern 
countries, and Neolac, a third party dairy processor located in Mexico.  The 
Company did not have sales to these third party processors in the quarter 
ending September 30, 2005.

Note 4 - Subsequent Events

      Conversions: January 2005 Convertible Notes.  We converted $116,624 
of our January 2005 Convertible Promissory Notes into 945,348 shares of 
restricted common stock pursuant to notices of conversion, to Longview 
Equity Fund LP and Longview International Equity Fund LP at a fixed 
conversion price of $0.125 per share.  The conversion included $1,446 of 
accrued and unpaid interest on the converted amount.  We issued the common 
stock upon conversion pursuant to a Form SB-2 registration statement 
declared effective by the Securities and Exchange Commission on August 2, 
2005.

      Conversions: August 2005 Convertible Notes.  We converted $307,692 
of our August 2005 Convertible Promissory Notes into 2,500,332 of restricted 
common stock pursuant to a notice of conversion, to Longview Fund LP, 
Longview Equity Fund LP and Longview International Equity Fund LP, at a fixed 
conversion price of $0.125 per share.  The conversion included $4,850 of 
accrued and unpaid interest on the converted amount.  We issued the common 
stock upon conversion pursuant to a Form SB-2 registration statement declared 
effective by the Securities and Exchange Commission on August 2, 2005.


  F-17


ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND 
         RESULTS OF OPERATIONS - NINE MONTHS ENDED SEPTEMBER 30, 2005

FORWARD-LOOKING STATEMENTS 

      Statements that are not historical facts, including statements about 
the Company's prospects and strategies and the Company's expectations about 
growth contained in this report are "forward-looking statements" within the 
meaning of Section 27A of the Securities Act of 1933, as amended, and 
Section 21E of the Securities Exchange Act of 1934, as amended.  These 
forward-looking statements represent the present expectations or beliefs 
concerning future events.  The Company cautions that such forward-looking 
statements involve known and unknown risks, uncertainties and other factors 
which may cause the Company's actual results, performance or achievements 
to be materially different from any future results, performance or 
achievements expressed or implied by such forward-looking statements.  Such 
factors include, among other things, the uncertainty as to the Company's 
future profitability; the uncertainty as to whether the Company's new 
business model can be implemented successfully; the accuracy of the 
Company's performance projections; and the Company's ability to obtain 
financing on acceptable terms to finance the Company's operations until 
profitability.

OVERVIEW

      The Company's business model includes the development and marketing 
of a Company owned Slammers(R) trademarked brand, the obtaining of license 
rights from third party holders of intellectual property rights to other 
trademarked brands, logos and characters and the granting of production and 
marketing rights to processor dairies to produce branded flavored milk.  
The Company generates revenue in its international (non-US) business 
through the sale of "kits" to these dairies.  The price of the "kits" 
consists of an invoiced price for a fixed amount of flavor ingredients per 
kit used to produce the flavored milk and a fee charged to the dairy 
processors for the production, promotion and sales rights for the branded 
flavored milk.  In the United States, the Company generates revenue from 
the unit sales of finished branded flavored milks to retail consumer 
outlets.  

      The Company's new product introduction and growth expansion continues 
to be expensive, and the Company reported a net loss of $7,386,564 for the 
nine-month period ended September 30, 2005.  As shown in the accompanying 
financial statements, the Company has suffered operating losses and 
negative cash flows from operations since inception and at September 30, 
2005 has an accumulated deficit of $41,386,594, and negative working capital 
of $4,105,854.  These conditions give rise to substantial doubt about the 
Company's ability to continue as a going concern.  As discussed herein, the 
Company has executed a ten year exclusive Master Distribution Agreement with 
Coca-Cola Enterprises Inc., the implementation of which commenced November 1, 
2005, is working toward profitability in the Company's U.S. and international 
business and will obtain additional financing.  While there is no assurance 
that funding will be available or that the Company will be able to improve 
the Company's operating results, the Company is continuing to seek equity 
and/or debt financing.


  18


No assurances can be given, however, that management will be successful in 
carrying out the Company's plans.  

CORPORATE GOVERNANCE

The Board of Directors

      The Company's board has positions for seven directors that are 
elected as Class A or Class B directors at alternate annual meetings of the 
Company's shareholders.  Six of the seven current directors of the 
Company's board are independent.  The Company's Chairman and Chief 
Executive Officer are separate.  The board meets regularly, at least four 
times a year, and all directors have access to the information necessary to 
enable them to discharge their duties.  The board, as a whole, and the 
audit committee in particular, reviews the Company's financial condition 
and performance on an estimated vs. actual basis and financial projections 
as a regular agenda item at scheduled periodic board meetings, based upon 
separate reports submitted by the Company's Chief Executive Officer and 
Chief Accounting Officer.  Directors are elected by the Company's 
shareholders after nomination by the board or are appointed by the board 
when a vacancy arises prior to an election.  The Company has adopted a 
nomination procedure based upon a rotating nomination committee made up of 
those members of the director class not up for election.  The board 
presently is examining whether this procedure, as well as the make up of 
the audit and compensation committees, should be the subject of an 
amendment to the by-laws.

Audit Committee

      The Company's audit committee is composed of three independent 
directors and functions to assist the board in overseeing the Company's 
accounting and reporting practices.  The Company's financial information is 
booked in house by the office of the Company's Chief Accounting Officer, 
from which the Company prepares financial reports.  These financial reports 
are audited or reviewed by Lazar Levine & Felix LLP, independent registered 
certified accountants and auditors.  The Company's CAO reviews the 
preliminary financial and non-financial information prepared in house with 
the Company's General Counsel and the auditors.  The committee reviews the 
preparation of the Company's audited and unaudited periodic financial 
reporting and internal control reports prepared by the Company's CAO.  The 
committee reviews significant changes in accounting policies and addresses 
issues and recommendations presented by the Company's auditors.  Currently, 
there is one vacancy on the audit committee.

Compensation Committee

      The Company's compensation committee is composed of three independent 
directors who review the compensation structure and policies concerning 
executive compensation.  The committee develops proposals and 
recommendations for executive compensation and presents those 
recommendations to the full board for consideration.  The committee 
periodically reviews the performance of the Company's other members of 
management and the recommendations of the Chief Executive Officer with 
respect to the compensation of those individuals.  Given the size of the 
Company, all such employment contracts are periodically reviewed by the 
board.  The board must approve all compensation packages that involve the 
issuance of the Company's stock or stock options.  


  19


Nominating Committee

      The nominating committee was established in the second quarter 2002 
and consists of those members of the director Class not up for election.  
The committee is charged with determining those individuals who will be 
presented to the shareholders for election at the next scheduled annual 
meeting.  The full board fills any mid term vacancies by appointment.

CRITICAL ACCOUNTING POLICIES

Estimates

      This discussion and analysis of the Company's consolidated financial 
condition and results of operations are based on the Company's consolidated 
financial statements, which have been prepared in accordance with 
accounting principles generally accepted in the United States of America.  
The preparation of these financial statements requires the Company to make 
estimates and disclosure of contingent assets and liabilities at the date 
of the financial statements and the reported amounts of revenues and 
expenses during the reporting period.  On an on-going basis, the Company 
evaluates the Company's estimates, including those related to reserves for 
bad debts and valuation allowance for deferred tax assets.  The Company 
bases its estimates on historical experience and on various other 
assumptions that are believed to be reasonable under the circumstances, the 
result of which forms the basis for making judgments about the carrying 
values of assets and liabilities that are not readily apparent from other 
sources.  Actual results may differ materially from these estimates under 
different assumptions or conditions.  The Company's use of estimates, 
however, is quite limited as the Company has adequate time to process and 
record actual results from operations.

Revenue recognition

United States
-------------

      The Company recognizes revenue in the United States at the gross 
amount of its invoices for the sale of finished product to wholesale buyers 
("unit sales").  The Company takes title to its branded flavored milks when 
they are shipped by the Company's third party processors and recognize as 
revenue the gross wholesale price charged to the Company's wholesale 
customers.  The Company's gross margin is determined by the reported 
wholesale price less the cost charged by Jasper Products, the Company's 
third party processor, to produce the branded milk products. 

      In certain circumstances in its U.S. business, the Company is 
required to pay slotting fees, give promotional discounts or make marketing 
allowances in order to secure wholesale customers.  These payments, 
discounts and allowances reduce the Company's reported revenue in 
accordance with the guidelines set forth in EITF 01-9 and SEC Staff 
Accounting Bulletin No. 104.


  20


International Sales
-------------------

      The Company generally recognizes revenue in its international 
business at the gross amount of its invoices for the sale of kits ("kit 
sales") at the time of shipment of flavor ingredients to processor dairies 
with which the Company has production contracts for extended shelf life and 
aseptic long life milk.  A "kit" consists of flavor ingredients and the 
grant of production rights for the Company's branded products.  The Company 
bases this recognition on its role as the principal in these transactions, 
its discretion in establishing kit sale prices (including the price of 
flavor ingredients and production right fees), its development and 
refinement of flavors and flavor modifications, its discretion in supplier 
selection and its credit risk to pay for ingredients if processors do not 
pay ingredient suppliers.  The revenue generated by the production 
contracts under this model consists of the cost of the processors' purchase 
of flavor ingredients and fees charged by the Company to the processors for 
production rights.  The Company formulates the price of production rights 
to cover the Company's intellectual property licenses, which varies by 
licensor as a percentage of the total cost of a kit sold to the processor 
dairy under the production agreement.  The Company recognizes revenue on 
the gross amount of "kit" invoices to the dairy processors and 
simultaneously records as cost of goods sold the cost of flavor ingredients 
paid by the processor dairies to ingredients supplier.  The recognition of 
revenue generated from the sale of production rights associated with the 
flavor ingredients is complete upon shipment of the ingredients to the 
processor, given the short utilization cycle of the ingredients shipped.

      Pursuant to EITF 99-19, international sales of kits made directly to 
customers by the Company are reflected in the statements of operations on a 
gross basis, whereby the total amount billed to the customer is recognized 
as revenue.  

      In certain circumstances, such as in the United Kingdom and as 
anticipated in Canada, the Company recognizes revenue under the unit sales 
model.


RESULTS OF OPERATIONS 

Financial Condition at September 30, 2005
-----------------------------------------

      As of September 30, 2005, we had an accumulated deficit of 
$41,485,761, cash on hand of $553,857 and reported total capital surplus of 
$7,544,377.

      For this same period of time, we had revenue of $6,591,693 and 
general and administrative expense of $2,345,041.

      After interest expenses of $293,415, cost of goods sold of 
$4,719,011, product development costs of $194,955 and selling expenses of 
$3,525,002 incurred in the operations of the Company, we had a net loss of 
$7,485,371.  Of this net loss amount, $3,000,000 has been recorded in the 
quarter ending September 30, 2005 as a one time, non-recurring finder's fee 
payable to a third-party in connection with the execution of the Master 
Distribution Agreement with Coca-Cola Enterprises, Inc. 


  21


Nine Months Ended September 30, 2005 Compared to the Nine Months Ended 
----------------------------------------------------------------------
September 30, 2004
------------------

Consolidated Revenue

      We had revenues for the nine months ended September 30, 2005 of 
$6,591,693, with cost of sales of $4,719,011, resulting in a gross margin 
of $1,872,682.  This revenue and resultant gross margin are net of slotting 
fees, promotional discounts and marketing allowances for this period in the 
amount of $330,699.  Of the reported revenue, U.S. sales accounted for 
$6,269,747, with $288,596 from UK unit sales and an additional $33,350 from 
international kit sales in the Middle East.  We did not have revenue in 
this period in Canada or Mexico.  Our reported revenue for the nine months 
ended September 30, 2005 increased by $3,886,701, a 143.69% increase 
compared to revenue of $2,704,992 for the same period in 2004.  This 
increase is the result of the Company's development of new branded product 
lines in the United States, including the 2005 launch of our Slammers(R) 
line of Mars' Starburst, MilkyWay and 3 Musketeers flavored milk drinks.  
Our launch of Mars Slammers(R) line in the first quarter 2005 achieved 
market penetration in over 30,000 grocery and convenience stores for this 
line by September 30, 2005.

Consolidated Cost of Sales 

      We incurred cost of goods sold of $4,719,011 for the nine months 
ended September 30, 2005, $4,506,616 of which was incurred in our U.S. 
business, $209,782 in connection with our UK operation and $2,613 in 
connection with our international sales in the Middle East.  Cost of goods 
sold in this period increased by $2,825,177 a 149.18% increase compared to 
$1,893,834 for the same period in 2004.  The increase in cost of goods sold 
reflects an increase in sales, the concomitant increase in reported cost of 
goods sold associated with that increase and the economic inefficiencies of 
low production volume associated with the initial launch of the Slammers(R) 
line in the UK.

      In countries except the United States and the United Kingdom, our 
revenue is generated by the sale of kits to dairy processors.  Each kit 
consists of flavor ingredients for flavored milks and production rights to 
manufacture and sell the milks.  In line with our revenue recognition 
policies, we recognize the full invoiced kit price as revenue, less the 
cost of production charged by the processor, which we record as cost of 
goods sold.  

      In the United States and the United Kingdom, we are responsible for 
the sale of finished Slammers(R) flavored milk (referred to as "unit 
sales") to retail outlets.  For these unit sales, we recognize as revenue 
the invoiced wholesale prices that we charge to the retail outlets that 
purchase the Slammers(R) flavored milks.  We report as cost of goods sold 
the price charged to the Company by third party processors that produce the 
finished Slammers(R) products.

Segmented Revenues and Costs of Sales

      The following table presents revenue by source and type against costs 
of goods sold, as well as combined gross revenues and gross margins.  In 
countries other than the United States 


  22


and the United Kingdom , revenues for the period ended September 30 2005 
were generated by kit sales to third party processors.  The Company's 
revenue from the sale of finished product to retail outlets is recorded as 
"unit sales" on the following table.  




Nine Months Ended                                                              United          Total
September 30, 2005                 United States     Mexico     Middle East    Kingdom        Company
------------------                 -------------     ------     -----------    -------        -------

                                                                             
Revenue - unit sales                $ 6,269,747     $      -     $      -     $ 288,596     $ 6,558,343
Revenue - gross kit sales                     -            -       33,350             -          33,350
                                    -----------     --------     --------     ---------     -----------
Total revenue                         6,269,747            -       33,350       288,596       6,591,693
Cost of goods sold                   (4,506,616)           -       (2,613)     (209,782)     (4,719,011)
                                    -----------     --------     --------     ---------     -----------

Gross margin                        $ 1,763,131     $      -     $ 30,737     $  78,814     $ 1,872,682
                                    ===========     ========     ========     =========     ===========



Nine Months Ended                                                              United          Total
September 30, 2004                 United States     Mexico     Middle East    Kingdom        Company
------------------                 -------------     ------     -----------    -------        -------

                                                                             
Revenue - unit sales                $ 2,236,383     $      -     $      -     $       -     $ 2,236,383
Revenue - gross kit sales                65,461       83,518      319,630             -         468,609
                                    -----------     --------     --------     ---------     -----------
Total revenue                         2,301,844       83,518      319,630             -       2,704,992
Cost of goods sold                   (1,820,432)     (31,101)     (42,301)            -      (1,893,834)
                                    -----------     --------     --------     ---------     -----------

Gross margin                        $   481,412     $ 52,417     $277,329     $       -     $   811,158
                                    ===========     ========     ========     =========     ===========


      United States
      -------------

      Revenues for the period ended September 30, 2005 from unit sales in 
the United States increased from $2,236,383 for the same period in 2004 to 
$6,269,747 in 2005, a 180.4% increase.  The increase is the result of the 
introduction of the Company's new product lines during this period.

      In the period ended September 30, 2005, our gross margin for U.S. 
sales of $1,763,131, increased by $1,281,719, or by 266.24%, from $481,412 
for the same period in 2004.  The increase in gross margin was the result 
of the increased sales and greater efficiencies in the production of our 
products.

      Foreign Sales
      -------------

      Revenues for the period ended September 30, 2005 from kit sales in 
foreign countries decreased from $403,148 for the same period in 2004 to 
$321,946, a 20.14 % decrease.  The decrease is the result of the lack of 
sales in Mexico and a reduction of sales in the Middle East during this 
period offset by the commencement of sales in the United Kingdom.

      We recorded $212,395 in costs of sales in foreign countries for the 
period ended September 30, 2005, an increase of $138,993 or 189.36% from 
$73,402 for the same period in 


  23


2004.  The increase was the result of the costs associated with 
establishing a new business in the United Kingdom based upon the Company's 
unit sales model.  

      For the period ended September 30, 2005, our gross profit of $109,551 
for sales in foreign countries decreased by $220,195, or 66.78%, from 
$329,746 for the same period in 2004.  The decrease in gross profit was 
consistent with the decrease in sales volume for this period. 

Consolidated Operating Expenses 

      We incurred selling expenses of $3,525,002 for the period ended 
September 30, 2005, $3,260,493 of which was incurred in our United States 
operations.  Our selling expense for this period increased by $2,254,960, a 
177.5% increase compared to our selling expense of $1,270,042 for the same 
period in 2004.  The increase in selling expenses in the current period was 
due to increased freight and promotional charges, including media 
advertising, associated with increased sales and our development of four 
new product lines, utilizing newly licensed and directly owned branded 
trademarks. In addition, the Company recorded $99,168, pro-rata, of an 
$11,900,000 net charge in deferred distribution costs for the issuance of a 
three warrant to Coca-Cola Enterprises to purchase of 30,000,000 shares of 
our common stock in connection with the execution of a Master Distribution 
Agreement. The Company will recognize that cost as a selling expense over 
the 10-year term of the Master Distribution Agreement.

      We incurred general and administrative expenses of $2,345,041 for the 
period ended September 30, 2005, $2,183,598 of which we incurred in our 
United States business operations and $161,443 for the enlargement of our 
international business into the United Kingdom and Canada.  Our general and 
administrative expenses for this period increased by $131,715, a 5.95% 
increase compared to $2,213,326 for the same period in 2004.  

      As a percentage of total revenue, the Company's general and 
administrative expenses decreased from 81.8% in the period ended September 
30, 2004, to 35.6% for the current period in 2005.  We anticipate a 
continued effort to reduce these expenses as a percentage of sales through 
revenue growth, cost cutting efforts and the refinement of business 
operations.

Interest Expense

      We incurred interest expense for the period ended September 30, 2005 
of $293,415.  Our interest expense increased by $138,598, a 89.52% increase 
compared to $154,817 for the same period in 2004.  The increase was due to 
using additional debt to finance the Company's operations during this 
period, including the development and launch of new product lines and 
expenses associated with increased promotional and marketing sponsorships.

Loss Per Share 

      We accrued dividends payable of $263,001 for various series of 
preferred stock during the period ended September 30, 2005.  The accrued 
dividends decreased for this period by $28,459, or 9.76%, from $291,460 for 
the same period in 2004.  The net loss before accrued dividends for the 
current period increased $4,603,600, from $2,882,131 for the period ended 
September 30, 2004 to $7,485,731 for the current period.  The increase in 
the net loss resulted in an increase in the Company's current period loss 
per share from $0.08 for the same period in 2004, to a loss per share of 
$0.09 for the current period.  Of the $7,485,370 net loss, $3,000,000 has 
been recorded in the quarter ending September 30, 2005 as a one time, non-
recurring finder's fee payable to a third party in connection with the 
execution of the Master Distribution 


  24


Agreement with Coca-Cola Enterprises, Inc.  Absent the $3,000,000 non-
recurring finder's fee charge, the Company's increased net loss per share 
was offset by an increase in the weighted average of common shares 
outstanding from 38,254,305 shares for the nine months ended September 
2004 to 82,091,556 shares for the current nine month period, resulting in a 
current period loss per share of $0.06.

Three Months Ended September 30, 2005 Compared to the Three Months Ended 
------------------------------------------------------------------------
September 30, 2004
------------------

Revenue 

      The Company had revenues for the three months ended September 30, 
2005 of $3,245,305, with cost of sales of $2,360,884, resulting in a gross 
profit of $884,421, or 27.3% of sales, $2,956,709 of which were generated 
by the Company's U.S. operation and $288,596 from the Company's UK 
business.  The Company did not report any sales for Canada, Mexico or the 
Middle East in the three months ended September 30, 2005.  Our revenue for 
the three months ended September 30, 2005 increased by $2,419,875, a 293% 
increase compared to revenue of $825,430 for the three months ended September 
30, 2005.  The increase in revenue in the United States for the three 
months ended September 30, 2005 is the result of the continuing rollout of 
the Company's new product lines during this period and the launch of the 
Company's business in the United Kingdom.

Cost of Goods Sold 

      The Company incurred cost of goods sold of $2,360,884 for the three 
months ended September 30, 2005, $2,151,102 of which was incurred in our 
U.S. operations in the third quarter.  Our cost of goods sold for this 
period increased by $1,732,137, a 275.5% increase compared to $628,747 for 
the three months ended September 30, 2004.  The increase in cost of goods 
sold in the United States for the three months ended September 30, 2005 is 
the result of increased sales and the corresponding increase in the costs 
of good sold.

Operating Expense 

      The Company incurred selling expenses of $1,727,531 for the three 
months ended September 30, 2005, $634,580 of which was incurred in our 
U.S. operation.  Selling expenses increased for the three months ended 
September 30, 2005 by $1,074,909, a 164.7% increase compared to the selling 
expense of $652,622 for the three months ended September 30, 2004.  The 
increase in selling expenses is the result of increased sales, including 
promotional expenses, the costs associated with guaranteed royalties under 
our third-party intellectual property license agreements and deferred 
distribution costs for the issuance of a warrant in connection wit the 
execution a Master Distribution Agreement with Coca-Cola Enterprises Inc. 

      The Company incurred general and administrative expenses of $905,487 
for the three months ended September 30, 2005, $844,464 of which was 
incurred in the U.S. operations.  General and administrative expenses for 
the three months ended September 30, 2005 increased by $354,188, a 64.25% 
increase compared to $551,299 for the same period in 2004.  The increase in 
general and administrative expenses for the current period is the result of 
greater management activities in the promotion and continued rollout of the 
Company's new product lines in the United States and the establishment of 
the Company's business in the United Kingdom.


  25


Interest Expense 

      The Company incurred interest expense for the three months ended 
September 30, 2005 of $73,169.  Interest expense for the three months ended 
September 30, 2005 decreased by $6,653, an 8.3% decrease compared to 
$79,822, for the same period in 2004.  This decrease was the result of 
of reduced debt in this period.

Net Loss 

      The Company had a net loss for the three months ended September 30, 
2005 of $4,906,456 compared with a net loss of $1,120,992 for the same 
period in 2004.  The net loss increased by $3,785,464 or 337.7% compared 
to the same period in 2004.  Of the $4,906,456 net loss, $3,000,000 represents 
a one time, non-recurring finder's fee payable to a third party in connection 
with the execution of the Master Distribution Agreement with Coca-Cola 
Enterprises, Inc.  Absent the $3,000,000 non-recurring finder's fee charge, 
the Company's increased net loss per share was offset by an increase in the 
weighted average of common shares outstanding from 44,374,877 shares for the 
three months ending September 2004 to 113,680,645 shares for the current three 
month period, resulting in a current three month period loss per share of 
$0.016.


LIQUIDITY AND CAPITAL RESOURCES

      As of September 30, 2005, we reported that net cash used in operating 
activities was $4,956,448, net cash provided by financing activities was 
$5,510,649 and net cash used in investing activities was $90,583.  We had a 
negative working capital of $4,105,854 as of September 30, 2005. 

      Compared to $3,372,840 of net cash used in operating activities in 
the period ended September 30, 2004, our current period net cash used in 
operating activities increased by $1,583,608 to $4,956,448.  This increase 
was the result of changes in deferred product development costs, prepaid 
expenses, accounts payable and accrued expenses, including a $3,000,000
finder's fee payable in connection with the execution of the Coca-Cola 
Enterprises Master Distribution Agreement.  Included in the net loss in 
this current period were depreciation and amortization and stock compensation 
for a finder fee aggregating $907,087, compared to $364,995 for the same period 
in 2004.  

      Changes in accounts receivable in this current period in 2005 
resulted in a cash decrease of $149,281, compared to a cash decrease in 
receivables of $8,490 for the same period in 2004, having a net result of 
an decrease of $140,791.  The changes in accounts payable and accrued 
liabilities in the period ended of September 30, 2004 contributed to a cash 
decrease of $224,031, whereas the changes in accounts payable and accrued 
liabilities for the current period in 2005 amounted to an increase of 
$4,208,414.  Cash flow generated through our operating activities was 
inadequate to cover all of our cash disbursement needs in the period ended 
September 30, 2005, and we had to rely on equity and debt financing to 
cover expenses.


  26


      Cash used in the period ended September 30, 2005 in our investing 
activities for equipment was $90,583 for software, computer equipment, 
telephone system, Company van, mobile communication devices and leasehold 
improvements in the U.S., compared to $47,647 for the same period in 2004. 

      Net cash provided by our financing activities for the period ended 
September 30, 2005 was $5,510,649.  Net cash provided by financing 
activities for the same period in 2004 was $3,419,891.  The increase was 
due to a greater need for financing to fund the Company's operations during 
this period and the exercise of warrants generating $2,958,509.

      The Company used the proceeds of the current period financing for 
working capital purposes to support the continued launch of new product 
lines under a license with Masterfoods USA and for new product development.

      Going forward, our primary requirements for cash consist of the 
following:

      *     the continued development of our business model in the United 
            States and on an international basis; 
      *     promotional and logistic production support for the capacity 
            demands presented by our Master Distribution Agreement with 
            Coca-Cola Enterprises
      *     general overhead expenses for personnel to support the new 
            business activities; 
      *     development, launch and marketing costs for our line of new 
            branded flavored milk products, and 
      *     the payment of guaranteed license royalties. 

      We estimate that our need for financing to meet cash requirements for 
operations will continue through the fourth quarter of 2005, when we expect 
that cash supplied by operating activities will approach the anticipated 
cash requirements for operating expenses.  We anticipate the need for 
additional financing in 2005 to reduce our liabilities, assist in marketing 
and to improve shareholders' equity status.  No assurances can be given 
that we will be able to obtain additional financing, or that operating cash 
flows will be sufficient to fund our operations. 

      We currently have monthly working capital needs of approximately 
$300,000.  We will continue to incur significant selling and other expenses 
in 2005 in order to derive more revenue in retail markets, through the 
introduction and ongoing support of our new products and the implementation 
of the Master Distribution Agreement with Coca-Cola Enterprises.  Certain 
of these expenses, such as slotting fees and freight charges, will be 
reduced as a function of unit sales costs as we expand our sales markets 
and increase our sales within established markets.  Freight charges will be 
reduced as we are able to ship more full truckloads of product given the 
reduced per unit cost associated with full truckloads versus less than full 
truckloads.  Similarly, slotting fees, which are paid to warehouses or 
chain stores as initial set up or shelf space fees, are essentially one-
time charges per new customer.  We believe that along with the increase in 
our unit sales volume, the average unit selling expense and associated 
costs will decrease, resulting in gross margins sufficient to mitigate cash 
needs.  In addition, we are actively seeking additional financing to 
support our operational needs and to develop an expanded promotional 
program for our products. 


  27


Material Events
---------------

      In January 2005, we launched our Slammers(R) Starburst line of Fruit 
& Cream Smoothies utilizing a "shelf stable" re-sealable plastic bottle for 
milk products that does not require refrigeration.  Until that launch, all 
single served flavored milk in plastic bottles required refrigeration for 
storage, distribution, and shelf placement.  The tactical advantage of 
distributing milk products ambient enables us to side-step a major entry 
barrier in our immediate consumption strategy.  Refrigerated milk is 
relegated to dairy direct-store-delivery systems that are controlled by 
either regional dairy processors or larger national dairy holding 
companies.  Shelf stable re-sealable plastic bottle allows us to use a more 
traditional distribution network that accommodates the non-refrigerated 
beverages.  Also, milk products packaged in shelf stable re-sealable 
plastic bottles have significantly longer shelf life for storage, allowing 
us to ship in full truckloads resulting in decreased freight costs.  We 
currently are converting all of our products to "shelf stable" re-sealable 
plastic bottle. 

      On July 13, 2005, Coca-Cola Enterprises Inc. (CCE) acquired options 
to purchase shares of common stock, convertible securities and warrants, 
entitling Coca-Cola Enterprises to purchase approximately 69,000,000 shares 
of common stock from 9 non-affiliated shareholders of the Company (the 
"Options"), representing approximately 23% of the authorized shares of the 
Company's common stock.  Coca-Cola Enterprises and the Company 
contemporaneously commenced negotiations regarding a stock purchase 
agreement for the direct sale of approximately 81 million shares of the 
Company's common stock to Coca-Cola Enterprises.  The consummation of the 
direct sale and the exercise of the Options by Coca-Cola Enterprises would 
have resulted in Coca-Cola Enterprises holding slightly in excess of 50% of 
the Company's equity on a fully diluted basis.  These transactions were 
contingent upon the execution of a Master Distribution Agreement between 
the Company and Coca-Cola Enterprises.  On July 29, 2005, the Company and 
Coca-Cola Enterprises entered into a Letter of Intent memorializing and 
confirming their intention to enter into the stock purchase agreement. 

      Subsequent to the execution of the Letter of Intent, in lieu of the 
exercise of the Options and the stock purchase agreement, the parties 
agreed to enter into the Master Distribution Agreement with the attendant 
grant of three year warrants by the Company to Coca-Cola Enterprises for 
the right to purchase 30 million shares of the Company's common stock at an 
exercise price of $0.36 per share.  On August 31, 2005, the Company issued 
the warrants to Coca-Cola Enterprises and the parties executed a ten year 
exclusive Master Distribution Agreement that will significantly expand the 
distribution and sales of the Company's products. The Company will recognize 
a $11,900,000 net charge in deferred distribution costs for the warrant issued 
to Coca-Cola Enterprises over the 10-year term of the Master Distribution 
Agreement. The Company presently is seeking from $10 - $15 million in new 
financing to promote the expanded sales anticipated with the implementation 
of the Master Distribution Agreement, and for general working capital.

External Sources of Liquidity 
-----------------------------

      Individual Loans 
      ----------------

      On November 6 and 7, 2001, respectively, we received the proceeds of 
two loans aggregating $100,000 from two offshore lenders.  The two 
promissory notes, one for $34,000 and the other for $66,000, were payable 
February 1, 2002 and bear interest at the annual rate of 


  28


8%.  These loans are secured by a general security interest in all our 
assets. On February 1, 2002, the parties agreed to extend the maturity 
dates until the completion of the anticipated Series H financing.  On 
September 18, 2002, the respective promissory note maturity dates were 
extended by agreement of the parties to December 31, 2002.  On September 
18, 2002, we agreed to extend the expiration dates of warrants issued in 
connection with our Series D and F preferred until September 17, 2005 and 
to reduce the exercise price of certain of those warrants to $1.00, in 
partial consideration for the maturity date extension. The holders of these 
notes have agreed to extend the maturity dates, and the notes are now 
payable on a demand basis. 

      On May 6, 2004, we issued a secured promissory note to Mid- Am 
Capital LLC in the principal amount of $750,000.  The note provides for 8% 
interest.  The note's original maturity date of September 4, 2004 has been 
extended.  We issued warrants to purchase 3,000,000 shares of our common 
stock to Mid-Am in connection with this promissory note.  The warrants are 
exercisable for one year from issue at an exercise price of $0.25 per 
share. We used the proceeds of this promissory note to pay the promissory 
note issued to Jasper Products in January 2004. 

      Convertible Debentures
      ----------------------

      To obtain funding for our ongoing operations, we entered into the 
following financing transactions in 2005.  

January 2005
------------

      On January 31, 2005, we closed a funding transaction with Longview 
Fund, LP, Longview Equity Fund, LP, Longview International Equity Fund, LP, 
Alpha Capital Aktiengesellschaft and Whalehaven Funds Limited, five 
institutional accredited investors, for the issuance and sale to the 
Subscribers of up to $2,300,000 of principal amount of promissory notes 
convertible into shares of our common stock, and Warrants to purchase 
shares of common stock at 100% coverage of the common stock issuable in 
accordance with the principal amount of the notes.  One Million One Hundred 
Fifty Thousand Dollars ($1,150,000) of the purchase price was paid on the 
initial closing date, and One Million One Hundred Fifty Thousand Dollars 
($1,150,000) of the purchase price will be payable within five (5) business 
days after the actual effectiveness of an SB-2 Registration Statement as 
defined in the Subscription Agreement.  

      The initial closing notes were at prime plus 4% interest in the 
aggregate amount of $1,150,000, plus five-year Warrants for the purchase 
of, in the aggregate, 9,200,000 shares of common stock, at the lesser of 
(i) $0.16, or (ii) 101% of the closing bid price of the Common Stock as 
reported by Bloomberg L.P. for the OTC Bulletin Board for the trading day 
preceding the Closing Date.    

      The notes are convertible into shares of our common stock at $0.125 
per common share.  Conversions are limited to a maximum ownership of 9.99% 
of the underlying common stock at any one time.  The notes have a maturity 
date two yeas from closing and are payable in twelve equal monthly 
installments, commencing June 1, 2005.  The installment payments consist of 
principal equal to 1/20th of the initial principal amount which, subject to 
certain conditions concerning trading volume and price, can be paid in cash 
at 103% of the monthly installment, or common stock or a combination of 
both.  The notes have an acceleration provision upon the 


  29


change in a majority of the present Board of Directors except as the result 
of the death of one or more directors, or a change in the present CEO.  In 
connection with this transaction, we issued restricted common stock in the 
aggregate amount of 460,000 shares plus the aggregate cash amount of 
$57,500 for due diligence fees to the investors in this transaction

April 2005
----------

      On April 21, 2005, the Company closed a funding transaction with one 
institutional investor for the issuance and sale to the Subscriber of a 
promissory note of the Company in the principal amount of $300,000.  The 
promissory note bears 10% interest and is convertible into shares of common 
stock of the Company at $0.20 per common share.  Conversions are limited to 
a maximum ownership of 9.99% of the Company's common stock at any one time.  

      The note has an October 31, 2005 maturity and is payable in five 
equal monthly installments, commencing June 1, 2005.  The installment 
payments consist of principal and equal to 1/5th of the initial principal 
amount plus accrued interest.  Installments can be paid in cash or common 
stock valued at the average closing price of the Company's common stock 
during the five trading days immediately preceding the relevant installment 
due date.  The Company has repriced Class B Warrants issued on June 30, 
2004 form $2.00 per share to $0.125 per share, and shall issue common stock 
in the aggregate amount of 93,750 shares for finder's fees to a third-party 
to facilitate this transaction.  

      The Company has the right to prepay the promissory note by paying to 
the holder cash equal to 120% of the principal to be prepaid plus accrued 
interest.  The notes have an acceleration provision upon the change in a 
majority of the present Board of Directors except as the result of the 
death of one or more directors, or a change in the present CEO of the 
Company.

May 2005
--------

      On May 23, 2005, we closed a funding transaction (the "May '05 
Transaction") with Longview Fund, LP, Whalehaven Funds Limited, Ellis 
International Ltd., and Osher Capital Corp., four institutional accredited 
investors, for the issuance and sale to the Subscribers of Five Hundred 
Thousand Dollars ($500,000) of principal amount of promissory notes 
convertible into shares of our common stock, and Warrants to purchase 
shares of common stock at 100% coverage of the common stock issuable in 
accordance with the principal amount of the notes.  

      This May '05 Transaction is a part of a January 23, 2005 funding 
transaction for an aggregate of Two Million Three Hundred Thousand Dollars 
($2,300,000), One Million One Hundred Fifty Thousand Dollars ($1,150,000) 
of which was paid on the initial closing date, and One Million One Hundred 
Fifty Thousand Dollars ($1,150,000) of which (the "Second Tranche") was to 
be payable within five (5) business days after the actual effectiveness of 
an SB-2 Registration Statement covering the aggregate transaction, as 
defined in the Subscription Agreement.  The May '05 Transaction for Five 
Hundred Thousand Dollars ($500,000) is a partial interim closing of the 
Second Tranche, which occurred prior to the anticipated effectiveness of 
the SB-2 Registration Statement covering the aggregate transaction.  
Contemporaneous with the May '05 Transaction, we agreed to a modification 
of the January 23, 2005 aggregate transaction for the substitution of Ellis 
International Ltd., and Osher Capital 


  30


Corp. in the place of Alpha Capital Aktiengesellschaft, one of the original 
investors.  The May '05 Transaction convertible notes are at prime plus 4% 
interest in the aggregate amount of $500,000, plus five-year Warrants for 
the purchase of, in the aggregate, 4,000,000 shares of common stock, at an 
exercise price of $0.129.  The notes are convertible into shares of our 
common stock at $0.125 per common share.  Conversions are limited to a 
maximum ownership of 9.99% of the underlying common stock at any one time.  
The notes have a maturity date two years from closing and are payable in 
twelve equal monthly installments, commencing June 1, 2005.  The 
installment payments consist of principal equal to 1/20th of the initial 
principal amount which, subject to certain conditions concerning trading 
volume and price, can be paid in cash at 103% of the monthly installment, 
or common stock or a combination of both.  The notes have an acceleration 
provision upon the change in a majority of the present Board of Directors 
except as the result of the death of one or more directors, or a change in 
the present CEO.  

      In connection with this transaction, we issued restricted common 
stock in the aggregate amount of 200,000 shares plus the aggregate cash 
amount of $25,000 for due diligence fees to Longview Fund, LP, Gem Funding 
LLC, Ellis International Ltd., and Osher Capital Corp. in this transaction.  
The Second Tranche of the January 23, 2005 aggregate transaction, now in 
the amount of $650,000, remains outstanding and will be triggered by the 
effectiveness of the pending SB-2 registration statement.

August 2005
-----------

      On August 18, 2005, we closed a funding transaction (the "August '05 
Transaction") with Longview Fund, LP, Longview Equity Fund, LP and Longview 
International Equity Fund, LP, three institutional accredited investors, 
for the issuance and sale to the Subscribers of Six Hundred Fifty Thousand 
Dollars ($650,000) of principal amount of promissory notes convertible into 
shares of our common stock and Warrants to purchase shares of common stock 
at 100% coverage of the common stock issuable in accordance with the 
principal amount of the notes.  This August'05 Transaction was a part of a 
January 23, 2005 funding transaction for an aggregate of Two Million Three 
Hundred Thousand Dollars ($2,300,000).  The August '05 Transaction is the 
Second Tranche of the January '05 transaction, which occurred upon the 
effectiveness of the SB-2 Registration Statement covering the aggregate 
transaction.  The August'05 Transaction convertible notes are at prime plus 
4% interest in the aggregate amount of $650,000, plus five-year Warrants 
for the purchase of, in the aggregate, 5,200,000 shares of common stock, at 
an exercise price of $0.129.  The notes are convertible into shares of our 
common stock at $0.125 per common share.  Conversions are limited to a 
maximum ownership of 9.99% of the underlying common stock at any one time.  
The notes have a maturity date two years from closing and are payable in 
twelve equal monthly installments.  The installment payments consist of 
principal equal to 1/20th of the initial principal amount which, subject to 
certain conditions concerning trading volume and price, can be paid in cash 
at 103% of the monthly installment, or common stock or a combination of 
both.  The notes have an acceleration provision upon the change in a 
majority of the present Board of Directors except as the result of the 
death of one or more directors, or a change in the present CEO.  In 
connection with this transaction, we issued restricted common stock in the 
aggregate amount of 260,000 shares plus the aggregate cash amount of 
$32,500 for due diligence fees to Longview Fund companies. 


  31


      On September 30, 2005, we repaid $250,000 of the aggregate $650,000 
of the August '05 Transaction notes, as follows: $57,692 to Longview Fund, 
LP, $144,231 to Longview Equity Fund, LP and $48,077 to Longview 
International Equity Fund, LP.  The holders of these notes waived the 
prepayment premium in lieu of their retention of warrants attached to 
August '05 Transaction.

EFFECTS OF INFLATION 

      We believe that inflation has not had any material effect on our net 
sales and results of operations. 

ITEM 3.  CONTROLS AND PROCEDURES

a)  Evaluation of Disclosure Controls and Procedures.  Our Chief Executive 
Officer and our principal accounting officer, after evaluating the 
effectiveness of our disclosure controls and procedures (as defined in the 
Securities Exchange Act of 1934 Rules 13a-14(c) and 15d-14(c) as of the 
filing date of this report on Form 10QSB (the Evaluation Date), have 
concluded that our disclosure controls and procedures were adequate and 
effective to ensure that material information relating to the Company and 
our consolidated subsidiary would be made known to them by others within 
those entities, particularly during the period in which this report on 
Form 10QSB was being prepared.

b)  Changes in Internal Controls. There were no changes in our internal 
controls or in other factors that could significantly affect our disclosure 
controls and procedures subsequent to the Evaluation Date, nor any 
significant deficiencies or material weaknesses in such disclosure controls 
and procedures requiring corrective actions.


PART II - OTHER INFORMATION

Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds

      Warrant Exercise: Series D Warrant.  We issued 696,042 shares of 
common stock to Longview Fund LP, Longview Equity Fund LP, Longview 
International Equity Fund LP and Esquire Trade & Finance Inc., pursuant to 
the cashless exercises of warrants for 763,750 shares of common stock. We 
issued the Warrants and the underlying common stock upon exercise to 
accredited investors, pursuant to a Regulation D offering and Rule 144(k).

      Conversions: Series F Convertible Preferred.  We converted 19,133 
shares of our Series F Convertible Preferred, having a stated value of 
$191,330 into 804,752 shares of common stock pursuant to notices of 
conversion to Amro International, SA.  We issued the Series F Convertible 
Preferred and the underlying common stock upon conversion to accredited 
investors, pursuant to a Regulation D offering and Rule 144(k).  

      Warrant Exercise: Series F Warrant.  We issued 3,345,417 shares of 
common stock to Austinvest Anstalt Balzers and Esquire Trade & Finance Inc. 
and Libra Finance, SA., pursuant to the cashless exercise of warrants for 
3,676,518 shares of common stock. We issued the Warrants 


  32


and the underlying common stock upon exercise to accredited investors, 
pursuant to a Regulation D offering and Rule 144(k).

      Conversions: Series H Convertible Preferred.  We converted 1,000 
shares of our Series H Convertible Preferred, having a stated value of 
$10,000 into 25,000 shares of common stock pursuant to notices of 
conversion, to one individual investor.  We issued the Convertible 
Preferred and the underlying common stock upon conversion to accredited 
investors, pursuant to a Regulation D offering and Rule 144(k).  

      Conversions: Series I Convertible Preferred.  We converted 10,000 
shares of our Series I Convertible Preferred, having a stated value of 
$100,000 into 656,953 shares of common stock pursuant to a notice of 
conversion, to Tradersbloom Limited.  The conversion included $24,000 of 
accrued and unpaid interest.  We issued the Convertible Preferred and the 
underlying common stock upon conversion to accredited investors, pursuant 
to a Regulation D offering and Rule 144(k).  

      Private Placements.  On August 3, 2005 we issued 500,000 restricted 
shares of our common stock to Geoffrey Eiten, for services rendered for 
strategic business planning.  We issued the restricted common stock 
pursuant to Section 4(6) of the Securities Act of 1933, which provides an 
exemption from the registration requirements of the Act for transactions 
not involving a public offering.

      On August 29 and September 19, 2005 we issued the aggregate of 
1,000,000 restricted shares of our common stock to National Financial 
Communications Corp. pursuant to the exercise of Warrants issued in 
connection with a consulting agreement for services rendered for strategic 
business planning.  We issued the restricted common stock pursuant to 
Section 4(6) of the Securities Act of 1933, which provides an exemption 
from the registration requirements of the Act for transactions not 
involving a public offering.

      On September 19, 2005, we issued 450,000 restricted shares of our 
common stock to Alpha Capital AG, an accredited investor, in a sale not 
involving a public offering at a price of $1.00 per share.  We issued the 
common stock pursuant to a Regulation D offering. 

      Warrant Issue.  On August 31, 2005, we issued three year Warrant to 
Coca-Cola Enterprises Inc. to purchase 30,000,000 shares of our common 
stock a $0.36 per share.  During the first 18 months of the exercise 
period, the Company has the option to "call" the exercise of up to 
10,000,000 shares of common stock issuable upon exercise of the Warrant, 
upon the Company's satisfaction of certain conditions, including a trading 
price of not less than $1.08 per share for 20 consecutive trading days.  
This Warrant was issued in connection with the execution of a Master 
Distribution Agreement on August 31, 2005.  We issued the Warrant pursuant 
to Section 4(6) of the Securities Act of 1933, which provides an exemption 
from the registration requirements of the Act for transactions not 
involving a public offering.

Subsequent Events

None


  33


Item 6.  Exhibits 

Exhibits - Required by Item 601 of Regulation S-B: 

      No. 10.1  Coca-Cola Enterprises Master Distribution Agreement

      No. 10.2  Oman National Dairy Products Co. Ltd. Production Agreement

      No. 10.3  Marvel Enterprises License (Middle East)

      No. 31:   Rule 13a-14(a) / 15d-14(a) Certifications

      No. 32:   Section 1350 Certifications

SIGNATURES

In accordance with the requirements of the Exchange Act of 1934, the 
registrant caused this report to be signed on its behalf of the 
undersigned, duly authorized.

BRAVO! FOODS INTERNATIONAL CORP.
(Registrant)
Date: November 14, 2005

/s/Roy G. Warren
Roy G. Warren, Chief Executive Officer



In accordance with the Securities Exchange Act of 1934, Bravo! Foods 
International Corp. has caused this report to be signed on its behalf by the 
undersigned in the capacities and on the dates stated.

Signature             Title                       Date
---------             -----                       ----

/S/ Roy G. Warren     Chief Executive Officer     November 14, 2005
                       and Director

/S/ Tommy E. Kee      Chief Accounting Officer     November 14, 2005


  34